We are honored to announce that Bioscience Equity Partners Pty Ltd has been awarded the title of Biotech & Med Tech Investment Enterprise of the Year 2024 by Global Health & Pharma (GHP) as part of their Healthcare & Pharmaceuticals Awards 2024.
See Award Post here.
Dr. George Syrmalis, CEO of Bioscience Equity Partners S.A., speaks with Medical Plastics News on how early-stage medical device companies must evolve beyond scientific strength and become institutionally ready for cross-border and sovereign capital.
Adding {{itemName}} to cart
Added {{itemName}} to cart